Our results suggest that NK-4 may prevent tissue damage and inflammation observed in allergic diseases by inhibiting the recruitment of eosinophils and Th2 cells through down-regulating the secretion of eotaxin and TARC by epithelial cells and fibroblasts in the lung and dermis in response to IL-4 and TNF-α. The gene discussed is IL32; the disease is allergic disease.